Drug intelligence / Profile preview

Dentyl

Development stage
Unknown
Lead developer
Venture Life Group
Modality
Small Molecules
Administration
Topical, Buccal
01

Overview

Dentyl (also known as Dentyl Dual Action or Dentyl Active) is a commercially available, alcohol-free, dual-phase mouthwash produced by Venture Life Group. Its formulation consists of an oil phase (containing isopropyl myristate) and a water phase (containing the antimicrobial agent cetylpyridinium chloride [CPC] and sodium fluoride) that combine when shaken. Dentyl acts by physically lifting and removing plaque and bacteria from the oral cavity, while CPC disrupts the lipid membranes of bacteria and enveloped viruses. During the COVID-19 pandemic, Dentyl was evaluated in clinical and in vitro studies, notably by Cardiff University, to determine its efficacy in reducing salivary SARS-CoV-2 viral load and potentially mitigating viral transmission.

Brand names
DentylDentyl Dual ActionDentyl ActiveDentyl pHDentyl Fresh Protect
Other names
cetylpyridinium chloride + sodium fluoride
02

Targets

Negatively charged bacterial surface within oral biofilm

Beyond the preview

Go deeper on Dentyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dentyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call